Transce3nd’s Globus Medical GMED Stock Holding History

Transce3nd’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-35	Closed	-$2.07K	–	550
2025 Q2	$2.07K	Hold	35	–	–	﹤0.01%	881
2025 Q1	$2.56K	Hold	35	–	–	﹤0.01%	830
2024 Q4	$2.9K	Buy	+35	New	+$2.76K	﹤0.01%	1049

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Transce3nd's GMED Position: Q3 2025 in Review

Transce3nd sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 35 shares — an estimated $2.07K sold.

Transce3nd first reported a position in GMED in Q4 2024 and held it in 3 quarters. The position peaked at $2.9K in Q4 2024. 489 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

Transce3nd reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 35 Globus Medical shares in Q3 2025, an estimated $2.07K.
Transce3nd first reported a position in Globus Medical in Q4 2024 and held it in 3 quarters.
Transce3nd's Globus Medical position peaked at $2.9K in Q4 2024.
489 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.